Baker JM - Search Results

1

Safety of single daily use for one week of C31G HEC gel in women.

Ballagh SA, Baker JM, Henry DM, Archer DF. Ballagh SA, et al. Among authors: baker jm. Contraception. 2002 Nov;66(5):369-75. doi: 10.1016/s0010-7824(02)00433-x. Contraception. 2002. PMID: 12443969 Clinical Trial.

2

Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.

Raymond EG, Singh M, Archer DF, Saxena BB, Baker J, Cole D. Raymond EG, et al. Fertil Steril. 1996 Dec;66(6):954-61. doi: 10.1016/s0015-0282(16)58689-0. Fertil Steril. 1996. PMID: 8941061 Free article.

3

A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.

Mauck CK, Baker JM, Barr SP, Abercrombie TJ, Archer DF. Mauck CK, et al. Among authors: baker jm. Contraception. 1997 Aug;56(2):89-96. doi: 10.1016/s0010-7824(97)00097-8. Contraception. 1997. PMID: 9315417 Clinical Trial.

4

A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.

Mauck CK, Baker JM, Barr SP, Johanson WM, Archer DF. Mauck CK, et al. Among authors: baker jm. Contraception. 1997 Aug;56(2):97-102. doi: 10.1016/s0010-7824(97)00099-1. Contraception. 1997. PMID: 9315418 Clinical Trial.

5

An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.

Mauck CK, Allen S, Baker JM, Barr SP, Abercrombie T, Archer DF. Mauck CK, et al. Among authors: baker jm. Contraception. 1997 Aug;56(2):103-10. doi: 10.1016/s0010-7824(97)00100-5. Contraception. 1997. PMID: 9315419 Clinical Trial.

6

A phase I study of Femcap used with and without spermicide. Postcoital testing.

Mauck CK, Baker JM, Barr SP, Johanson W, Archer DF. Mauck CK, et al. Among authors: baker jm. Contraception. 1997 Aug;56(2):111-5. doi: 10.1016/s0010-7824(97)00098-x. Contraception. 1997. PMID: 9315420 Clinical Trial.

7

Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. A possible mechanism of action of the intrauterine device.

Archer DF, DeSoto KR, Baker JM. Archer DF, et al. Among authors: baker jm. Contraception. 1999 Mar;59(3):175-9. doi: 10.1016/s0010-7824(99)00014-1. Contraception. 1999. PMID: 10382080 Clinical Trial.

8

The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.

Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R, Stock R, Pan Z, Morrison CS, Chen-Mok M, Archer DF, Gabelnick HL. Mauck CK, et al. Contraception. 1999 Jul;60(1):15-24. doi: 10.1016/s0010-7824(99)00058-x. Contraception. 1999. PMID: 10549448

9

A randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ring.

Weisberg E, Fraser IS, Baker J, Archer D, Landgren BM, Killick S, Soutter P, Krause T, d'Arcangues C. Weisberg E, et al. Contraception. 2000 Aug;62(2):83-9. doi: 10.1016/s0010-7824(00)00137-2. Contraception. 2000. PMID: 11102592 Clinical Trial.

10

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.

Pinkerton JV, Constantine G, Hwang E, Cheng RF; Study 3353 Investigators. Pinkerton JV, et al. Menopause. 2013 Jan;20(1):28-37. doi: 10.1097/gme.0b013e31826421a8. Menopause. 2013. PMID: 23010882 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters